Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

GnRH stimulant

DRUG CLASS:

GnRH stimulant

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

leuprorelin depot (1)

goserelin acetate sustained-release microspheres for injection (0)

leuprorelin implant (0)

leuprorelin depot (1)

goserelin acetate sustained-release microspheres for injection (0)

leuprorelin implant (0)

›

BRCA1 mutation + BRCA2 mutation	Prostate Cancer	BRCA1 mutation + BRCA2 mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3
CDK12 mutation	Prostate Cancer	CDK12 mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3
BRCA2 mutation	Prostate Cancer	BRCA2 mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3
ATM mutation	Prostate Cancer	ATM mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3
BRCA2 mutation + CDK12 mutation	Prostate Cancer	BRCA2 mutation + CDK12 mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3
BRCA2 mutation + CHEK2 mutation	Prostate Cancer	BRCA2 mutation + CHEK2 mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3
ATM mutation + CDK12 mutation	Prostate Cancer	ATM mutation + CDK12 mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3
BRCA2 A902fs*2	Prostate Cancer	BRCA2 A902fs*2	Prostate Cancer	abiraterone acetate + bicalutamide implant + leuprorelin depot Resistant: C4 – Case Studies abiraterone acetate + bicalutamide implant + leuprorelin depot Resistant : C4	abiraterone acetate + bicalutamide implant + leuprorelin depot Resistant: C4 – Case Studies abiraterone acetate + bicalutamide implant + leuprorelin depot Resistant : C4